Root	O
Cause	O
Analysis	O
of	O
Adverse	B:C0877248
Events	I:C0877248
in	O
an	O
Outpatient	O
Anticoagulation	O
Management	O
Consortium	O
.	O

Root	O
Cause	O
Analysis	O
of	O
Adverse	O
Events	I:C0877248
in	O
an	O
Outpatient	O
Anticoagulation	B:C2919015
Management	O
Consortium	O
.	O

Root	O
Cause	O
Analysis	O
of	O
Adverse	O
Events	I:C0877248
in	O
an	O
Outpatient	O
Anticoagulation	O
Management	B:C0376636
Consortium	O
.	O

Root	O
Cause	O
Analysis	O
of	O
Adverse	O
Events	I:C0877248
in	O
an	O
Outpatient	O
Anticoagulation	O
Management	O
Consortium	B:C1513822
.	O

A	O
number	O
of	O
factors	O
can	O
lead	O
to	O
adverse	B:C0877248
events	I:C0877248
(	O
adverse	O
events	I:C0877248
)	O
in	O
patients	O
taking	O
warfarin	O
.	O

A	O
number	O
of	O
factors	O
can	O
lead	O
to	O
adverse	O
events	I:C0877248
(	O
adverse	B:C0877248
events	I:C0877248
)	O
in	O
patients	O
taking	O
warfarin	O
.	O

A	O
number	O
of	O
factors	O
can	O
lead	O
to	O
adverse	O
events	I:C0877248
(	O
adverse	O
events	I:C0877248
)	O
in	O
patients	O
taking	O
warfarin	B:C0043031
.	O

Performing	O
a	O
root	O
cause	O
analysis	O
(	O
RCA	O
)	O
of	O
serious	O
adverse	B:C0877248
events	I:C0877248
is	O
one	O
systematic	O
way	O
of	O
determining	O
the	O
causes	O
of	O
these	O
events	O
.	O

Performing	O
a	O
root	O
cause	O
analysis	O
(	O
RCA	O
)	O
of	O
serious	O
adverse	O
events	I:C0877248
is	O
one	O
systematic	O
way	O
of	O
determining	O
the	O
causes	O
of	O
these	O
events	B:C0877248
.	O

Multidisciplinary	O
teams	O
were	O
formed	O
at	O
Michigan	B:C0025939
Anticoagulation	O
Quality	O
Improvement	O
Initiative	O
(	O
MAQI	O
(	O
2	O
)	O
)	O
sites	O
with	O
organized	O
anticoagulation	O
management	I:C0282196
services	I:C0282196
(	O
anticoagulation	O
management	I:C0282196
services	I:C0282196
)	O
.	O

Multidisciplinary	O
teams	O
were	O
formed	O
at	O
Michigan	O
Anticoagulation	O
Quality	O
Improvement	O
Initiative	O
(	O
MAQI	O
(	O
2	O
)	O
)	O
sites	O
with	O
organized	O
anticoagulation	B:C0282196
management	I:C0282196
services	I:C0282196
(	O
anticoagulation	O
management	I:C0282196
services	I:C0282196
)	O
.	O

Multidisciplinary	O
teams	O
were	O
formed	O
at	O
Michigan	O
Anticoagulation	O
Quality	O
Improvement	O
Initiative	O
(	O
MAQI	O
(	O
2	O
)	O
)	O
sites	O
with	O
organized	O
anticoagulation	O
management	I:C0282196
services	I:C0282196
(	O
anticoagulation	B:C0282196
management	I:C0282196
services	I:C0282196
)	O
.	O

Medical	B:C0025102
records	I:C0025102
from	O
patients	O
who	O
suffered	O
serious	O
adverse	O
events	I:C0877248
(	O
major	O
bleed	I:C3160769
,	O
embolic	O
stroke	I:C0262469
,	O
venous	O
thromboembolism	I:C1861172
)	O
were	O
reviewed	O
,	O
and	O
anticoagulation	O
management	I:C0282196
services	I:C0282196
staff	O
were	O
interviewed	O
to	O
determine	O
the	O
root	O
cause	O
using	O
the	O
"	O
5	I:C0282574
Whys	I:C0282574
"	I:C0282574
technique	I:C0282574
.	O

Medical	O
records	I:C0025102
from	O
patients	O
who	O
suffered	O
serious	O
adverse	B:C0877248
events	I:C0877248
(	O
major	O
bleed	I:C3160769
,	O
embolic	O
stroke	I:C0262469
,	O
venous	O
thromboembolism	I:C1861172
)	O
were	O
reviewed	O
,	O
and	O
anticoagulation	O
management	I:C0282196
services	I:C0282196
staff	O
were	O
interviewed	O
to	O
determine	O
the	O
root	O
cause	O
using	O
the	O
"	O
5	I:C0282574
Whys	I:C0282574
"	I:C0282574
technique	I:C0282574
.	O

Medical	O
records	I:C0025102
from	O
patients	O
who	O
suffered	O
serious	O
adverse	O
events	I:C0877248
(	O
major	B:C3160769
bleed	I:C3160769
,	O
embolic	O
stroke	I:C0262469
,	O
venous	O
thromboembolism	I:C1861172
)	O
were	O
reviewed	O
,	O
and	O
anticoagulation	O
management	I:C0282196
services	I:C0282196
staff	O
were	O
interviewed	O
to	O
determine	O
the	O
root	O
cause	O
using	O
the	O
"	O
5	I:C0282574
Whys	I:C0282574
"	I:C0282574
technique	I:C0282574
.	O

Medical	O
records	I:C0025102
from	O
patients	O
who	O
suffered	O
serious	O
adverse	O
events	I:C0877248
(	O
major	O
bleed	I:C3160769
,	O
embolic	B:C0262469
stroke	I:C0262469
,	O
venous	O
thromboembolism	I:C1861172
)	O
were	O
reviewed	O
,	O
and	O
anticoagulation	O
management	I:C0282196
services	I:C0282196
staff	O
were	O
interviewed	O
to	O
determine	O
the	O
root	O
cause	O
using	O
the	O
"	O
5	I:C0282574
Whys	I:C0282574
"	I:C0282574
technique	I:C0282574
.	O

Medical	O
records	I:C0025102
from	O
patients	O
who	O
suffered	O
serious	O
adverse	O
events	I:C0877248
(	O
major	O
bleed	I:C3160769
,	O
embolic	O
stroke	I:C0262469
,	O
venous	B:C1861172
thromboembolism	I:C1861172
)	O
were	O
reviewed	O
,	O
and	O
anticoagulation	O
management	I:C0282196
services	I:C0282196
staff	O
were	O
interviewed	O
to	O
determine	O
the	O
root	O
cause	O
using	O
the	O
"	O
5	I:C0282574
Whys	I:C0282574
"	I:C0282574
technique	I:C0282574
.	O

Medical	O
records	I:C0025102
from	O
patients	O
who	O
suffered	O
serious	O
adverse	O
events	I:C0877248
(	O
major	O
bleed	I:C3160769
,	O
embolic	O
stroke	I:C0262469
,	O
venous	O
thromboembolism	I:C1861172
)	O
were	O
reviewed	O
,	O
and	O
anticoagulation	B:C0282196
management	I:C0282196
services	I:C0282196
staff	O
were	O
interviewed	O
to	O
determine	O
the	O
root	O
cause	O
using	O
the	O
"	O
5	I:C0282574
Whys	I:C0282574
"	I:C0282574
technique	I:C0282574
.	O

Medical	O
records	I:C0025102
from	O
patients	O
who	O
suffered	O
serious	O
adverse	O
events	I:C0877248
(	O
major	O
bleed	I:C3160769
,	O
embolic	O
stroke	I:C0262469
,	O
venous	O
thromboembolism	I:C1861172
)	O
were	O
reviewed	O
,	O
and	O
anticoagulation	O
management	I:C0282196
services	I:C0282196
staff	B:C0851286
were	O
interviewed	O
to	O
determine	O
the	O
root	O
cause	O
using	O
the	O
"	O
5	I:C0282574
Whys	I:C0282574
"	I:C0282574
technique	I:C0282574
.	O

Medical	O
records	I:C0025102
from	O
patients	O
who	O
suffered	O
serious	O
adverse	O
events	I:C0877248
(	O
major	O
bleed	I:C3160769
,	O
embolic	O
stroke	I:C0262469
,	O
venous	O
thromboembolism	I:C1861172
)	O
were	O
reviewed	O
,	O
and	O
anticoagulation	O
management	I:C0282196
services	I:C0282196
staff	O
were	O
interviewed	O
to	O
determine	O
the	O
root	O
cause	O
using	O
the	O
"	B:C0282574
5	I:C0282574
Whys	I:C0282574
"	I:C0282574
technique	I:C0282574
.	O

More	O
than	O
600	O
patients	O
had	O
an	O
AE	B:C0877248
and	O
underwent	O
screening	O
by	O
trained	O
RNs	O
.	O

More	O
than	O
600	O
patients	O
had	O
an	O
AE	O
and	O
underwent	O
screening	B:C0220908
by	O
trained	O
RNs	O
.	O

More	O
than	O
600	O
patients	O
had	O
an	O
AE	O
and	O
underwent	O
screening	O
by	O
trained	O
RNs	B:C1522486
.	O

All	O
potential	O
contributing	O
factors	O
(	O
comorbidities	O
,	O
concurrent	O
medications	B:C2081612
,	O
current	O
protocols	O
)	O
were	O
assessed	O
to	O
determine	O
the	O
main	O
factor	O
that	O
caused	O
the	O
AE	O
.	O

All	O
potential	O
contributing	O
factors	O
(	O
comorbidities	O
,	O
concurrent	O
medications	O
,	O
current	O
protocols	B:C0442711
)	O
were	O
assessed	O
to	O
determine	O
the	O
main	O
factor	O
that	O
caused	O
the	O
AE	O
.	O

All	O
potential	O
contributing	O
factors	O
(	O
comorbidities	O
,	O
concurrent	O
medications	O
,	O
current	O
protocols	O
)	O
were	O
assessed	O
to	O
determine	O
the	O
main	O
factor	O
that	O
caused	O
the	O
AE	B:C0877248
.	O

Most	O
identified	O
adverse	B:C0877248
events	I:C0877248
,	O
55/69	O
(	O
80	O
%	O
)	O
,	O
were	O
due	O
to	O
patient	O
-	O
specific	O
factors	O
such	O
as	O
comorbidities	O
.	O

Patient	O
-	O
to-	O
provider	B:C0018724
and	O
provider	O
-	O
to-	O
provider	O
communication	O
accounted	O
for	O
16/69	O
(	O
23	O
%	O
)	O
of	O
events	O
and	O
was	O
the	O
second	O
most	O
common	O
cause	O
.	O

Patient	O
-	O
to-	O
provider	O
and	O
provider	B:C0018724
-	O
to-	O
provider	O
communication	O
accounted	O
for	O
16/69	O
(	O
23	O
%	O
)	O
of	O
events	O
and	O
was	O
the	O
second	O
most	O
common	O
cause	O
.	O

Patient	O
-	O
to-	O
provider	O
and	O
provider	O
-	O
to-	O
provider	B:C0018724
communication	O
accounted	O
for	O
16/69	O
(	O
23	O
%	O
)	O
of	O
events	O
and	O
was	O
the	O
second	O
most	O
common	O
cause	O
.	O

Patient	O
-	O
to-	O
provider	O
and	O
provider	O
-	O
to-	O
provider	O
communication	O
accounted	O
for	O
16/69	O
(	O
23	O
%	O
)	O
of	O
events	B:C0877248
and	O
was	O
the	O
second	O
most	O
common	O
cause	O
.	O

Other	O
causes	O
included	O
protocol	B:C0442711
non-adherence	O
and	O
technology	O
/	O
equipment	O
issues	O
.	O

Other	O
causes	O
included	O
protocol	O
non-adherence	O
and	O
technology	B:C0752189
/	O
equipment	O
issues	O
.	O

Other	O
causes	O
included	O
protocol	O
non-adherence	O
and	O
technology	O
/	O
equipment	O
issues	B:C0033213
.	O

After	O
each	O
detailed	O
review	O
,	O
the	O
multidisciplinary	O
panel	O
recommended	O
system	B:C0018696
changes	O
that	O
addressed	O
the	O
primary	O
cause	O
.	O

The	O
majority	O
of	O
severe	O
adverse	B:C0877248
events	I:C0877248
for	O
patients	O
taking	O
warfarin	O
were	O
related	O
to	O
nonmodifiable	O
patient	O
-	O
related	O
issues	O
.	O

The	O
majority	O
of	O
severe	O
adverse	O
events	I:C0877248
for	O
patients	O
taking	O
warfarin	B:C0043031
were	O
related	O
to	O
nonmodifiable	O
patient	O
-	O
related	O
issues	O
.	O

The	O
majority	O
of	O
severe	O
adverse	O
events	I:C0877248
for	O
patients	O
taking	O
warfarin	O
were	O
related	O
to	O
nonmodifiable	O
patient	O
-	O
related	O
issues	B:C0033213
.	O

The	O
remaining	O
adverse	B:C0877248
events	I:C0877248
were	O
primarily	O
due	O
to	O
patient	O
-	O
to	O
-	O
provider	O
and	O
provider	O
-	O
to-	O
provider	O
communication	O
issues	O
.	O

The	O
remaining	O
adverse	O
events	I:C0877248
were	O
primarily	O
due	O
to	O
patient	O
-	O
to	O
-	O
provider	B:C0018724
and	O
provider	O
-	O
to-	O
provider	O
communication	O
issues	O
.	O

The	O
remaining	O
adverse	O
events	I:C0877248
were	O
primarily	O
due	O
to	O
patient	O
-	O
to	O
-	O
provider	O
and	O
provider	B:C0018724
-	O
to-	O
provider	O
communication	O
issues	O
.	O

The	O
remaining	O
adverse	O
events	I:C0877248
were	O
primarily	O
due	O
to	O
patient	O
-	O
to	O
-	O
provider	O
and	O
provider	O
-	O
to-	O
provider	B:C0018724
communication	O
issues	O
.	O

The	O
remaining	O
adverse	O
events	I:C0877248
were	O
primarily	O
due	O
to	O
patient	O
-	O
to	O
-	O
provider	O
and	O
provider	O
-	O
to-	O
provider	O
communication	O
issues	B:C0033213
.	O

